Vertanical launches medical cannabis Exilby in Europe
medical cannabis Exilby launches in Germany and Austria after EU approval for chronic low back pain. FDA Breakthrough granted; US Phase 3 trial of 810
Tag: FDA
Winston-Salem Seeks medical cannabis Research Hub
Wake Forest-backed Winston-Salem seeks medical cannabis research role, surveys centuries of therapeutic use, FDA cannabinoid drugs, and federal barriers.
DEA Hearing Tests cannabis rescheduling Proposal
DEA hearing on cannabis rescheduling draws seven opposition groups; FDA witness defends 252-page HHS analysis, two-part CAMU test, and 2023 recommendation.
FDA Grants Breakthrough to VERTANICAL cannabis extract
VERTANICAL’s VER-01 cannabis extract with 2.5 mg THC gains FDA Breakthrough after Phase 3 showed greater pain reduction than opioids. Company announced.
House Bill Targets Cannabis Rescheduling and Enforcement
The U.S. House Appropriations Committee is scrutinizing the Biden administration’s cannabis rescheduling process as part of the Fiscal Year 2026…
Lawmakers Criticize FDA for Poor Oversight of Intoxicating Hemp Products
Lawmakers harshly criticized the US Food and Drug Administration (FDA) during a hearing on April 9, 2025. They claimed that…
Trump Administration Appears to Retreat on Cannabis Rescheduling
In a recent episode of the Trade To Black podcast, host Shadd Dales and co-host Anthony Varrell discussed the latest…